Search research articles
Contact Us
Filters
Showing results (41-50 of 122) with videos related to
Page
of 13
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
April 22, 2009
[Analysis of NPM1 gene mutations in acute myeloid leukemia]
Dan Dai, Su-Jiang Zhang, Chun Qiao, et al.
Journal of Fungi (Basel, Switzerland)
|
May 24, 2024
The Discovery of Acremochlorins O-R from an <i>Acremonium</i> sp. through Integrated Genomic and Molecular Networking
Ge Cui, Luning Zhou, Hanwei Liu, et al.
Leukemia Research
|
March 31, 2009
The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis
Su-Jiang Zhang, Jian-Yong Li, Jian-Fu Zhang, et al.
Aging
|
April 3, 2020
Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML
Ming Hong, Han Zhu, Qian Sun, et al.
Chinese Journal of Natural Medicines
|
March 27, 2019
Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis
Wei-Wei Qin, Li Wang, Zheng Jiao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 11, 2021
[A Retrospective Analysis of TKI Discontinuation in Patients with CML]
Xiao-Li Zhao, Ming Hong, Chun Qiao, et al.
Metabolism: Clinical and Experimental
|
April 28, 2019
YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis
Tingting Yang, Fanglin Shu, Hao Yang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 23, 2008
[Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]
Wei Xu, Jian-Yong Li, Zhi-Hong Zhang, et al.
Chinese Medical Journal
|
December 16, 2020
Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation
Si-Si Chen, Qian Sun, Lan Cao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 27, 2024
[Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with <i>FLT3</i> Mutations]
Yang Chen, Yan-Yan Xie, Yu Fang, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 122) with videos related to
Sort By:
Page
of 13
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
April 22, 2009
[Analysis of NPM1 gene mutations in acute myeloid leukemia]
Dan Dai, Su-Jiang Zhang, Chun Qiao, et al.
Journal of Fungi (Basel, Switzerland)
|
May 24, 2024
The Discovery of Acremochlorins O-R from an <i>Acremonium</i> sp. through Integrated Genomic and Molecular Networking
Ge Cui, Luning Zhou, Hanwei Liu, et al.
Leukemia Research
|
March 31, 2009
The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis
Su-Jiang Zhang, Jian-Yong Li, Jian-Fu Zhang, et al.
Aging
|
April 3, 2020
Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML
Ming Hong, Han Zhu, Qian Sun, et al.
Chinese Journal of Natural Medicines
|
March 27, 2019
Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis
Wei-Wei Qin, Li Wang, Zheng Jiao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 11, 2021
[A Retrospective Analysis of TKI Discontinuation in Patients with CML]
Xiao-Li Zhao, Ming Hong, Chun Qiao, et al.
Metabolism: Clinical and Experimental
|
April 28, 2019
YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis
Tingting Yang, Fanglin Shu, Hao Yang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 23, 2008
[Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]
Wei Xu, Jian-Yong Li, Zhi-Hong Zhang, et al.
Chinese Medical Journal
|
December 16, 2020
Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation
Si-Si Chen, Qian Sun, Lan Cao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 27, 2024
[Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with <i>FLT3</i> Mutations]
Yang Chen, Yan-Yan Xie, Yu Fang, et al.
Page
of 13